2014
DOI: 10.1186/1471-2369-15-45
|View full text |Cite
|
Sign up to set email alerts
|

Regression methods for investigating risk factors of chronic kidney disease outcomes: the state of the art

Abstract: BackgroundChronic kidney disease (CKD) is a progressive and usually irreversible disease. Different types of outcomes are of interest in the course of CKD such as time-to-dialysis, transplantation or decline of the glomerular filtration rate (GFR). Statistical analyses aiming at investigating the association between these outcomes and risk factors raise a number of methodological issues. The objective of this study was to give an overview of these issues and to highlight some statistical methods that can addre… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

0
32
0

Year Published

2015
2015
2023
2023

Publication Types

Select...
9
1

Relationship

0
10

Authors

Journals

citations
Cited by 33 publications
(33 citation statements)
references
References 60 publications
0
32
0
Order By: Relevance
“…36 The intraindividual variation in the GFR measurements calculated from this subset was lower than in most previous studies and indicates a low level of measurement error. 25,37 The repeated followup measurements were included in the linear mixed models and allowed adjustment for intraindividual variation in the analyses.…”
Section: Discussionmentioning
confidence: 71%
“…36 The intraindividual variation in the GFR measurements calculated from this subset was lower than in most previous studies and indicates a low level of measurement error. 25,37 The repeated followup measurements were included in the linear mixed models and allowed adjustment for intraindividual variation in the analyses.…”
Section: Discussionmentioning
confidence: 71%
“…eGFR was calculated using the following equation: eGFR (ml/min/1.73 m 2 ) = 194 × serum creatinine (−1.094) × age (−0.287) × 0.739 (if female) 27 . The slope of eGFR decline over one year was calculated by standard linear models using the data of eGFR at biopsy, 6 months and one year after biopsy as reported previously 28 . Hypertension was defined as systolic BP ≥140 mmHg and/or diastolic BP ≥90 mmHg or if the patient indicated the use of antihypertensive drugs.…”
Section: Methodsmentioning
confidence: 99%
“…Therefore, we chose to measure within-person change in eGFR, which is inherently independent of between-person factors. Assuming that the main drivers of the within-person measurement error in the eGFR are constant, and if calculated across a number of time points, then eGFR decline at the level of the individual will be less affected by factors that are not related to the progressive kidney damage of interest [1214]. …”
Section: Introductionmentioning
confidence: 99%